stockrow
Friday 6 November 2026
Export SMMT’s income statement to Excel — free account
Summit Therapeutics PLC
SMMT Healthcare Biotechnology
Summit Therapeutics PLC’s revenue for fiscal 2022 (year ended December 2022) was $705,000.00.
- EPS
- +63.2%
- Free cash flow
- −112.8%
Quarter to June 2026, against a year earlier
15.85
1.66
+11.70%
Follow SMMT
Alert me
Summit Therapeutics PLC (SMMT) Revenue growth
Summit Therapeutics PLC's revenue growth over the twelve months to 31 December 2022 was −61.0%. Over the past ten years it has ranged from −98.7% (fiscal 2019) to 971.1% (fiscal 2018); the current reading is higher than 30% of that period. That is below the Biotechnology industry median of 6.26% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2022 | −61.0% | (171.38) |
| FY2021 | 110.4% | 94.60 |
| FY2020 | 15.8% | 114.45 |
| FY2019 | −98.7% | (353.85) |
| FY2019 | 255.2% | 306.58 |
| FY2018 | −51.4% | (1,022.54) |
| FY2018 | 971.1% | 970.92 |
| FY2017 | 0.19% | (242.04) |
| FY2017 | 242.2% | 313.01 |
| FY2016 | −70.8% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Dec 2022 | −100.0% | (16.81) |
| Sep 2022 | −83.2% | (395.47) |
| Jun 2022 | 312.3% | 282.07 |
| Mar 2022 | 30.2% | (5.47) |
| 23 more quarters | Free account |
Against its own ten years
Low −98.7%
High 971.1%
Ten-year median
7.97%
Current reading's percentile
30
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BBIO BridgeBio Pharma, Inc. compare | 167.3% |
| KYMR Kymera Therapeutics, Inc. compare | 134.8% |
| ASND Ascendis Pharma A/S compare | 126.0% |
| HALO Halozyme Therapeutics, Inc. compare | 45.0% |
| BMRN BioMarin Pharmaceutical Inc. compare | 18.1% |
| JAZZ Jazz Pharmaceuticals PLC compare | 13.5% |
| TECH Bio-Techne Corp compare | −0.38% |
| SMMT Summit Therapeutics PLC | −61.0% |
| PCVX Vaxcyte, Inc. compare | — |
| Biotechnology industry median | 6.26% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on SMMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement